These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity. Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531 [TBL] [Abstract][Full Text] [Related]
24. Addendum to "Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism". Folsom AR Am J Hematol; 2007 Jul; 82(7):698. PubMed ID: 17373679 [No Abstract] [Full Text] [Related]
25. Factor VII-activating protease: coagulation, fibrinolysis, and atherothrombosis? Mann KG Circulation; 2003 Feb; 107(5):654-5. PubMed ID: 12578860 [No Abstract] [Full Text] [Related]
26. Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism. Folsom AR; Cushman M; Heckbert SR; Ohira T; Rasmussen-Torvik L; Tsai MY J Thromb Haemost; 2007 Aug; 5(8):1674-8. PubMed ID: 17663738 [TBL] [Abstract][Full Text] [Related]
27. Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study. Aleksic N; Folsom AR; Cushman M; Heckbert SR; Tsai MY; Wu KK J Thromb Haemost; 2003 Jan; 1(1):88-94. PubMed ID: 12871544 [TBL] [Abstract][Full Text] [Related]
28. Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis. Zee RY; Cook NR; Cheng S; Erlich HA; Lindpaintner K; Ridker PM Circulation; 2006 May; 113(18):2193-200. PubMed ID: 16651467 [TBL] [Abstract][Full Text] [Related]
30. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis. Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176 [TBL] [Abstract][Full Text] [Related]
31. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. von Depka M; Czwalinna A; Wermes C; Eisert R; Scharrer I; Ganser A; Ehrenforth S Thromb Haemost; 2003 May; 89(5):847-52. PubMed ID: 12719783 [TBL] [Abstract][Full Text] [Related]
33. A common polymorphism in the tumour necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thromboembolism. Brown K; Luddington R; Baglin T Br J Haematol; 1998 Jun; 101(3):480-2. PubMed ID: 9633890 [TBL] [Abstract][Full Text] [Related]
34. More on: thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. Kubisz P; Stasko J; Hollý P; Ivanková J; Pullmann R J Thromb Haemost; 2005 Dec; 3(12):2825-7. PubMed ID: 16359529 [No Abstract] [Full Text] [Related]
35. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene: really a risk factor for venous thromboembolism? Okumus G; Arseven O Thromb Haemost; 2003 Nov; 90(5):766-7. PubMed ID: 14597966 [No Abstract] [Full Text] [Related]
36. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis. Corral J; González-Conejero R; Soria JM; González-Porras JR; Pérez-Ceballos E; Lecumberri R; Roldán V; Souto JC; Miñano A; Hernández-Espinosa D; Alberca I; Fontcuberta J; Vicente V Blood; 2006 Jul; 108(1):177-83. PubMed ID: 16527896 [TBL] [Abstract][Full Text] [Related]
37. Plasma homocysteine levels, methylene tetrahydrofolate reductase polymorphisms, and the risk of thromboembolism in children. Nahar A; Sabo C; Chitlur M; Ravindranath Y; Lusher J; Rajpurkar M J Pediatr Hematol Oncol; 2011 Jul; 33(5):330-3. PubMed ID: 21602719 [TBL] [Abstract][Full Text] [Related]
38. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Corral J; González-Conejero R; Iniesta JA; Rivera J; Martínez C; Vicente V Haematologica; 2000 Mar; 85(3):293-7. PubMed ID: 10702819 [TBL] [Abstract][Full Text] [Related]
39. The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1. Ravin AJ; Edwards RP; A Krohn M; Kelley JR; Christopherson WA; Roberts JM Obstet Gynecol; 2002 Dec; 100(6):1285-9. PubMed ID: 12468175 [TBL] [Abstract][Full Text] [Related]
40. Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP). Nielsen NV; Roedel E; Manna D; Etscheid M; Morth JP; Kanse SM Sci Rep; 2019 Dec; 9(1):18990. PubMed ID: 31831842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]